GlassScriptPhysician profile
Tara Holder
NPI 1588027254
$20,229.07
in general payments reported to CMS, 2019-2025
35 companies · $8,290 in 2025
The $8,290 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $254 · 2022: $3,601 · 2023: $6,209 · 2024: $1,875 · 2025: $8,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,943 · Consulting Fee: $5,387 · Travel and Lodging: $4,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,942.53 |
| Consulting Fee | $5,386.50 |
| Travel and Lodging | $4,044.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $6,926.24 | 2025 | |
| Abbott Laboratories | $3,678.66 | 2022-2025 | Supera, Acculink, Xience Skypoint |
| Medtronic, INC. | $3,203.39 | 2021-2023 | Venaseal, Onyx Frontier |
| Boston Scientific Corporation | $1,163.77 | 2022-2025 | Avvigo Guidance System, Watchman Flx, Opticross |
| Cardiovascular Systems INC. | $1,094.49 | 2022 | |
| Shockwave Medical, INC | $871.99 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $428.28 | 2022-2025 | (Bs0) Mechanical Atherectomy, Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und |
| Novartis Pharmaceuticals Corporation | $376.06 | 2023-2025 | |
| Amgen INC. | $341.42 | 2021-2025 | Repatha, Repatha |
| Inari Medical, INC. | $335.59 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $281.06 | 2022 | |
| Penumbra, INC. | $249.30 | 2023-2025 | Indigo System, Penumbra System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $220.28 | 2021-2025 | Lifevest |
| Abiomed | $145.22 | 2024-2025 | Impella |
| Kiniksa Pharmaceuticals, LTD. | $122.84 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $96.07 | 2023-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $94.88 | 2023-2025 | Farxiga, Andexxa |
| E.R. Squibb & Sons, L.L.C. | $80.69 | 2024-2025 | Eliquis, Camzyos |
| Surmodics, INC. | $61.14 | 2024 | Pounce Thrombectomy, Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.98 | 2023-2025 | Jardiance |
| Terumo Medical Corporation | $52.93 | 2023-2025 | Tr Band, Angio-Seal, Metacross Otw |
| Kestra Medical Technology Services, INC. | $47.49 | 2023-2024 | Assure Wcd |
| Teleflex LLC | $37.36 | 2025 | Turnpike |
| Cagent Vascular INC | $36.80 | 2025 | Serrantor |
| Actelion Pharmaceuticals US, INC. | $33.68 | 2025 | Opsumit |
| Reflow Medical INC | $32.17 | 2024 | |
| Daiichi Sankyo INC. | $24.46 | 2023 | Injectafer |
| Janssen Scientific Affairs, LLC | $20.03 | 2023 | Xarelto |
| Chiesi USA, INC. | $19.41 | 2025 | Kengreal |
| Kiniksa Pharmaceuticals International, Plc | $18.52 | 2024 | Arcalyst |
| Pfizer INC. | $18.35 | 2024 | |
| Merck Sharp & Dohme LLC | $18.13 | 2025 | Verquvo |
| Atricure, INC. | $16.32 | 2024 | |
| Bard Peripheral Vascular, INC. | $15.44 | 2024 | Rotarexs 6 F X 135 Cm |
| Cordis US Corp. | $13.63 | 2024 | Mynx Venous Vcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Holder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.